Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Fiduciary Trust Co

Fiduciary Trust Co increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,286 shares of the medical equipment provider’s stock after buying an additional 111 shares during the period. Fiduciary Trust Co’s holdings in Intuitive Surgical were worth $5,369,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $25,000. Hurley Capital LLC acquired a new position in Intuitive Surgical during the 4th quarter worth $28,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth about $26,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. Finally, BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $536.55 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $379.67 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $500.93 and a 200-day simple moving average of $534.71. The company has a market capitalization of $192.31 billion, a price-to-earnings ratio of 83.71, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period last year, the business posted $1.50 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently weighed in on ISRG. Royal Bank of Canada cut their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Barclays decreased their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Finally, Evercore ISI lowered their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.